Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study-Reference-Cited by-同舟云学术

Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study

Published:2012-08 Issue:4 Volume:12 Page:238-243
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Foss Francine,Horwitz Steven M.,Coiffier Bertrand,Bartlett Nancy,Popplewell Leslie,Pro Barbara,Pinter-Brown Lauren C.,Shustov Andrei,Furman Richard R.,Haioun Corinne,Koutsoukos Tony,O'Connor Owen A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches;Foss;Leuk Lymphoma,2003

2. Transformed mycosis fungoides: clinicopathological features and outcome;Barberio;Br J Dermatol,2007

3. Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine;Awar;Oncology,2007

4. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation;Arulogun;Blood,2008

5. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis;Diamandidou;Blood,1998

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children;Transplantation and Cellular Therapy;2024-04

2. Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches;Journal of Biomolecular Structure and Dynamics;2024-02-24

3. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma;Expert Review of Anticancer Therapy;2024-01-26

4. Mycosis Fungoides and Sézary Syndrome;Cancer Consult;2023-11-18

5. Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments;Frontiers in Immunology;2023-10-05